ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rivaroxaban-Mepha 15 mg, Hartkapseln - 98
69305008 Mepha Pharma AG
Rivaroxaban-Mepha 15 mg, Hartkapseln31.01.2025
  31.01.2025
Rivaroxaban (B01AF01) 
WHO-DDD30.01.2030
98
06.03. 
B  
No 
  
PR  
k.A.PR
  
7680693050082Synthetika
  
Composition
rivaroxabanum 15.0 mg, cellulosum microcristallinum, lactosum monohydricum 19.50 mg, tricalcii dicitras tetrahydricus, povidonum K 25, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: E 172 (flavum), E 171, carrageenanum, kalii chloridum, aqua purificata, hypromellosum, pro capsula corresp. natrium 0.38 mg et kalium 0.14 mg.
Packungsbestandteile
Capsules
 
 
Active AgentDose
Rivaroxabanum15 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
Aqua Purificata  
Carmellosum Natricum Conexum  
Carrageenanum  
Cellulosum Microcristallinum  
E 171 color.
E 172 Kapselhülle
Hypromellosum  
Potassium Chloride  
Lactose Monohydrate19.5 mg 
Magnesii Stearas  
Natrii Laurilsulfas  
Povidonum K25  
Silica Colloidalis Anhydrica  
Tricalcii Dicitras Tetrahydricus  
Source
Data was imported : 07.02.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home